Potential of NOTCH1 Mutation to Predict Anti-PD1 Treatment Outcomes in Patients with Oesophageal Squamous Cell Cancer By Ogkologos - April 23, 2025 840 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from a biomarker analysis from the RATIONALE-302 study Source RELATED ARTICLESMORE FROM AUTHOR ESMO Announces 2026 Society Award Recipients Honouring Excellence in Cancer Research, Care and Leadership Adjuvant Olaparib Continues to Improve Multiple Outcomes in Patients with Germline BRCA1/2-associated High-Risk HER2-negative EBC EMA Recommends Refusing the Marketing Authorisation for Copper (64Cu) Oxodotreotide MOST POPULAR Study Shows Music Eases Pain and Other Symptoms for Patients Undergoing... June 6, 2019 AI-Supported Mammography Screening Shows Favourable Outcomes Compared with Standard Double Reading February 12, 2026 Studying “Total Diet” and Its Impact on Health, Including Cancer Risk October 25, 2018 Combination of Immunotherapy Drugs Approved for Metastatic Colorectal Cancer August 3, 2018 Load more HOT NEWS “The power of science”: HPV vaccine proven to dramatically reduce cervical... Ενθαρρυντικά δεδομένα για ασθενείς με προχωρημένο μελάνωμα που έλαβαν θεραπεία με... Good-bye, Old Friend Our sun safety messaging tours the UK with the NIVEA Sun...
